FDA-Inspected Site

Medipharm Laboratories, Inc

2 FDA inspections are on record for Medipharm Laboratories, Inc in Miami, United States.

483· Form 483 issued

Miami, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-02-23.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
21 Feb 2024 – 23 Feb 2024Human Drugs483View 483 →
25 Jan 2017 – 31 Jan 2017Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

23 Feb 2024
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Dorothy P Kramer, Alan A Rivera

23 Feb 2024
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Dorothy P Kramer, Alan A Rivera

31 Jan 2017
21 CFR 211.165(b)

Microbiological testing

Cited by Jennifer Lalama

31 Jan 2017
21 CFR 211.166(a)

Written program not followed

Cited by Jennifer Lalama

31 Jan 2017
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jennifer Lalama

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Medipharm Laboratories, Inc's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat